RxDoctor Payments Data

Susan Hake, MD

Family Medicine · North Canton, OHNPI 1558325373

Payments from drug & device makers

$1,806in general payments, 2019–2025

Across 125 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$333
  • AbbVie$251
  • Boehringer Ingelheim$163
  • Astellas Pharma US Inc$147
  • Pfizer$145
  • Amgen$113
  • plus $654 from 17 others

What the payments were for

  • Food & beverage$1,806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,806 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$61,436
Medicare patients
137
Services billed
644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$103,449
JardianceEmpagliflozin65$71,796
OzempicSemaglutide37$50,390
TrulicityDulaglutide19$40,993
XareltoRivaroxaban32$29,813
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$22,975
MyrbetriqMirabegron21$12,966
Incruse ElliptaUmeclidinium Bromide21$7,767
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$7,381
Breo ElliptaFluticasone/Vilanterol16$6,683
Spiriva HandihalerTiotropium Bromide12$5,879
Atorvastatin Calcium463$4,685
SynthroidLevothyroxine Sodium71$4,121
Pregabalin21$3,525
Omeprazole188$3,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$145$103,449113 claims
Boehringer IngelheimJardiance$163$71,79665 claims
Novo NordiskOzempic$333$50,39037 claims
Lilly USA, LLCTrulicity$108$40,99319 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$39$37,42473 claims
Astellas Pharma US IncMyrbetriq$147$12,96621 claims
AbbVieSynthroid$251$4,12171 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →